Results 111 to 120 of about 1,052,896 (217)
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response [PDF]
International audienceRNA-sensing toll-like receptors (TLRs) mediate innate immunity and regulate anti-viral response. We show here that TLR3 regulates host immunity and the loss of TLR3 aggravates pathology in Chikungunya virus (CHIKV) infection ...
Ng, Lisa +63 more
core +1 more source
Development of the Live-Attenuated Chikungunya Virus Vaccine Candidate CHIKV-NoLS
The causal pathogen of chikungunya virus disease, mosquito-transmitted chikungunya virus (CHIKV), has caused significant global epidemics of arthritic disease over the past two decades.
Rao, Shambhavi
core +1 more source
Chikungunya virus (CHIKV) is transmitted by mosquito bites and causes chikungunya fever (CHIKF). CHIKV has a single-stranded RNA genome and belongs to a single serotype with three genotypes.
Eduardo D. Rodríguez-Aguilar +2 more
doaj +1 more source
Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection. [PDF]
PURPOSE: Chikungunya virus (CHIKV) causes endemic or epidemic outbreaks of CHIKV fever, which is a mosquitoe- transmitted viral disease in Africa, India, South-East Asia, and recently Southern Europe.
Kim, J +5 more
core +1 more source
Design and Validation of Novel Chikungunya Virus Protease Inhibitors [PDF]
Chikungunya virus (CHIKV; genus Alphavirus) is the causative agent of chikungunya fever. CHIKV replication can be inhibited by some broad-spectrum antiviral compounds; in contrast, there is very little information about compounds specifically inhibiting ...
Ahola, Tero +8 more
core +1 more source
Chikungunya Virus as Cause of Febrile Illness Outbreak, Chiapas, Mexico, 2014
Since chikungunya virus (CHIKV) was introduced into the Americas in 2013, its geographic distribution has rapidly expanded. Of 119 serum samples collected in 2014 from febrile patients in southern Mexico, 79% were positive for CHIKV or IgM against CHIKV.
Tiffany F. Kautz +12 more
doaj +1 more source
The Chikungunya virus (CHIKV) causes Chikungunya fever, a disease characterized by symptoms such as arthralgia/polyarthralgia. Currently, there are no antivirals approved against CHIKV, emphasizing the need to develop novel therapies.
Sabino-Silva, Robinson +13 more
core +1 more source
Development of a serological assay for Chikungunya virus / Nishakanthi a/p Gopalan [PDF]
Chikungunya virus (CHIKV) is a RNA virus that belongs to the Alphavirus genus of the family Togaviridae. It is transmitted by Aedes albopictus and Aedes aegypti, and causes clinical symptoms like fever with acute fever, skin rash and athralgia which ...
Gopalan, Nishakanthi
core
Therapeutics and Vaccines Against Chikungunya Virus
Erratum in Correction to: Vector Borne Zoonotic Dis 2015;15(4):250-257 DOI: 10.1089/vbz.2014.1681. [Vector Borne Zoonotic Dis. 2015]International audienceCurrently, there are no licensed vaccines or therapies available against chikungunya virus (CHIKV)
Ann Powers +29 more
core +1 more source
Chikungunya virus (CHIKV) causes periodic outbreaks and is endemic in more than 110 countries. VIMKUNYA, a CHIKV virus-like particle (CHIKV VLP) vaccine, was recently approved by regulators in the United States, European Union, and United Kingdom ...
Lark L. Coffey +27 more
doaj +1 more source

